Differential Responsiveness of Human and Rat Mesothelioma Cell Lines to Recombinant Interferon-γ

American Journal of Respiratory Cell and Molecular Biology

Volumn 16, Issue 2, 1997, Pages 178-186

  Phan Bich, L ^b   Buard, A ^b   Petit, J F ^b   Zeng, L ^b   Tenu, J P ^b   Chretien, P ^b   Monnet, I ^b   Boutin, C ^b   Bignon, J ^b   Lemaire, G ^b   Jaurand, M C ^a  

^a INSERM   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

MURINAE; RODENTIA;

GAMMA INTERFERON; GAMMA INTERFERON RECEPTOR; INDOLEAMINE 2,3 DIOXYGENASE; INTERFERON RECEPTOR; LEUKOCYTE ANTIGEN; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; RECOMBINANT PROTEIN; TRYPTOPHAN 2,3 DIOXYGENASE;

ANIMAL; ARTICLE; BIOSYNTHESIS; CELL CULTURE; CELL DIVISION; ENZYME INDUCTION; ENZYMOLOGY; GENETICS; HUMAN; MESOTHELIOMA; METABOLISM; PATHOLOGY; PHYSIOLOGY; RAT;

ANIMALS; ANTIGENS, CD; CELL DIVISION; ENZYME INDUCTION; HUMANS; INDOLEAMINE-PYRROLE 2,3,-DIOXYGENASE; INTERFERON TYPE II; MESOTHELIOMA; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; RATS; RECEPTORS, INTERFERON; RECOMBINANT PROTEINS; TRYPTOPHAN OXYGENASE; TUMOR CELLS, CULTURED;

EID: 0031066833     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/ajrcmb.16.2.9032125     Document Type: Article

References (37)

1. Peto, J., J. T. Hodgson, F. E. Matthews, and J. R. Jones. 1995. Continuing increase in mesothelioma mortality in Britain. Lancet 345:535-539.
2. Boutin, C., E. Nussbaum, I. Monnet, J. Bignon, R. Vanderschueren, J. C. Guérin, O. Menard, P. Mignot, G. Dabouis, and J. Y. Douillard. 1994. Intrapleural treatment with recombinant gamma-interferon in early stage malignant pleural mesothelioma. Cancer 74:2460-2467.
3. Monti, G., M. C. Jaurand, I. Monnet, P. Chrétien, L. Saint-Etienne, L. Zeng, L. A. Portier, P. Devillier, P. Galanaud, J. Bignon, and D. Emilie. 1994. Intrapleural production of interleukin-6 during mesothelioma, and its modulation by interferon-γ treatment. Cancer Res. 54:4419-4423.
4. Zeng, L., A. Buard, I. Monnet, C. Boutin, J. Fleury, L. Saint-Etienne, P. Brochard, J. Bignon, and M. C. Jaurand. 1993. In vitro effects of recombinant humun interferon gamma on human mesothelioma cell lines. Int. J. Cancer 55:515-520.
5. Lepoivre, M., H. Boudbid, and J. F. Petit. 1989. Antiproliferative activity of γ-interferon combined with LPS on murine adenocarcinoma: dependence on an L-arginine metabolism with production of nitrite and citrulline. Cancer Res. 49:1970-1976.
6. Lepoivre, M., B. Chenais, A. Yapo, G. Lemaire, L. Thelander, and J. P. Tenu. 1990. Alterations of ribonucleotide reductase activity following induction of the nitrite-generating pathway in adenocarcinoma cells. J. Biol. Chem. 265:14143-14149.
7. Sherman, P. A., V. E. Laubach, B .R. Reep, and E. R. Wood. 1993. Purification and cDNA sequence of an inducible nitric oxide synthase from a human tumor cell line. Biochemistry 32:11600-11605.
8. Werner-Felmayer, G., E. R. Werner, D. Fuchs, A. Hausen, G. Reibnegger, and H. Wachter. 1989. Characteristics of interferon induced tryptophan metabolism in human cells in vitro. Biochim. Biophys. Acta 1012:140-147.
9. Ozaki, Y., M. P. Edelstein, and D. S. Duch. 1988. Induction of indoleamine 2,3-dioxygenase: a mechanism of the antitumor activity of interferon γ. Proc. Natl. Acad. Sci. USA 85:1212-1246.
10. Taylor, M., and G. Feng. 1991. Relationship between interferon-γ, indoleamine 2,3-dioxygenase and tryptophan catabolism. FASEB J. 5:2516-2522.
11. Jaurand, M. C., J. F. Bernaudin, A. Renier, H. Kaplan, and J. Bignon. 1981. Rat mesothelial cells in culture. In Vitro 17:98-106.
12. Patérour, M. J., J. Bignon, and M. C. Jaurand. 1985. In vitro transformation of rat pleural mesothelial cells by chrysotile fibers and/or benzo(a)pyrene. Carcinogenesis 6:523-529.
13. Saint-Etienne, L., S. Endo-Capron, and M. C. Jaurand. 1993. In vitro neoplastic transformation of rat pleural mesothelial cells. Eur. Respir. Rev. 3:141-144.
14. Zeng, L., J. Fleury-Feith, I. Monnet, C. Boutin, J. Bignon, and M. C. Jaurand. 1994. Immunocytochemical characterization of cell lines from human malignant mesothelioma: characterization of human mesothelioma cell lines by immunocytochemistry with a panel of monoclonal antibodies. Hum. Pathol. 25:227-234.
15. Chomczynski, P., and N. Sacchi. 1987. Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:156-159.
16. Aguet, M., I. Dembic, and G. Merlin. 1988. Molecular cloning and expression of the human interferon-γ receptor. Cell 55:273-280.
17. Nussler, A. K., M. Di Silvio, T. R. Billiar, R. A. Hoffman, D. A. Geller, R. Selby, J. Madariaga, and R. L. Simmons. 1992. Stimulation of the nitric oxide synthase pathway in human hepatocytes by cytokines and endotoxin. J. Exp. Med. 176:261-264.
18. Hibbs, J., R. Taintor, Z. Vavrin, D. Granger, J. C. Drapier, I. Amber, and J. Lancaster. 1990. Synthesis of nitric oxide from a terminal guanidino nitrogen atom of L-arginine: a molecular mechanism regulating cellular proliferation that targets intracellular iron. In Nitric Oxide from L-arginine: A Bioregulatory System. S. Moncada and E. A. Higgs, editors. Excerpta Medica, Amsterdam. 189-223.
19. Raddassi, K., B. Berthon, J. F. Petit, and G. Lemaire. 1994. Role of calcium in the activation of mouse peritoneal macrophages: induction of NO synthase by calcium ionophores and thapsigargin. Cell. Immunol. 153:443-455.
20. Junquero, D., T. Scott-Burden, V. Schini, W. Durante, A. Shafer, and P. Vanhoutte. 1992. Induction of nitric oxide production in human vascular smooth muscle cells by interleukin-1β and its inhibition by transforming growth factor-β. In The Biology of Nitric Oxide. 1. Physiological and Clinical Aspects. S. Moncada, M. Marletta, J. Hibbs, and E. Higgs, editors. Portland Press, London. 336-341.
21. Cameron, M., D. Granger, J. Weinberg, W. Kozumbo, and H. Koren. 1990. Human alveolar and peritoneal macrophages mediate fungistasis independently of L-arginine oxidation to nitrite or nitrate. Am. Rev. Respir. Dis. 142:1313-1319.
22. Murray, H., and R. Teitelbaum. 1992. L-arginine-dependent reactive nitrogen intermediates and the antimicrobial effect of activated human mononuclear phagocytes. J. Infect. Dis. 165:513-517.
23. Petit, J. F., L. Phan-Bich, G. Lemaire, C. Martinache, and M. Lopez. 1993. During their differentiation into macrophages, human monocytes acquire a cytostatic activity independent of NO and TNF-α. Res. Immunol. 144: 277-280.
24. Owens, M. W., and M. B. Grisham. 1993. Nitric oxide synthesis by rat pleural mesothelial cells: induction by cytokines and lipopolysaccharide. Am. J. Physiol. 65 (Lung Cell Mol. Physiol. 9):L110-L116.
25. Thomas, G., T. Ando, K. Verma, and E. Kagan. 1994. Asbestos fibers and interferon-γ up-regulate nitric oxide production in rat alveolar macrophages. Am. J. Respir. Cell Mol. Biol. 11:707-715.
26. Stein, C. S., Z. Fabry, S. Murphy, M. N. Hart. 1995. Involvement of nitric oxide in IFN-gamma-mediated reduction of microvessel smooth muscle cell proliferation. Mol. Immunol. 32:965-973.
27. Laveck, M. A., A. N. A. Somers, L. L. Moore, B. I. Gerwin, and J. F. Lechner. 1988. Dissimilar peptide growth factors can induced normal human mesothelial cell multiplication. In Vitro Cell. Dev. Biol. 24:1077-1084.
28. Gerwin, B. I. 1994. Mesothelial carcinogenesis. In The Mesothelial Cells and Mesothelioma. M.-C. Jaurand and J. Bignon, editors. Marcel Dekker, New York. 223-243.
29. Fitzpatrick, D. R., D. J. Peroni, and H. Bielefeldt-Ohmann. 1995. The role of growth factors and cytokines in the tumorigenesis and immunobiology of malignant mesothelioma. Am. J. Respir. Cell Mol. Biol. 12:455-460.
30. Fujino, S., A. Yokoyama, N. Kohno, and K. Hiwada. 1996. Interleukin 6 is an autocrine growth factor for normal human pleural mesothelial cells. Am. J. Respir. Cell Mol. Biol. 14:508-515.
31. Offner, F. A., P. Obrist, S. Stadlmann, H. Feichtinger, P. Klingler, M. Herold, H. Zwierzina, A. Hittmair, G. Mikuz, B. Abendstein, A. Zeimet, and C. Marth. 1995. IL-6 secretion by human peritoneal mesothelial and ovarian cancer cells. Cytokine 7:542-547.
32. Portier, M., X.-G. Zhang, E. Caron, Z.-Y. Lu, R. Bataille, and B. Klein. 1993. γ-interferon in multiple myeloma: inhibition of interleukin-6 (IL-6)-dependent myeloma cell growth and downregulation of IL-6-receptor expression in vitro. Blood 81:3076-3082.
33. Raitano, A. B., and M. Korc. 1993. Growth inhibition of a human colorectal carcinoma cell line by interleukin-1 is associated with enhanced expression of γ-interferon receptors. Cancer Res. 53:636-640.
34. Ng, S. B., Y. H. Tan, and G. R. Guy. 1994. Differential induction of the interleukin-6 gene by tumor necrosis factor and interleukin-1. J. Biol. Chem. 269:19021-19027.
35. Sironi, M., F. L. Sciacca, C. Matteucci, M. Conni, A. Vecchi, S. Bernasconi, A. Minty, D. Caput, P. Ferrara, F. Colotta, and A. Mantovani. 1994. Regulation of endothelial and mesothelial cell function by interleukin-13: selective induction of vascular cell adhesion molecule-1 and amplification of interleukin-6 production. Blood 84:1913-1921.
36. Topley, N., A. Jörres, W. Luttmann, M. M. Petersen, M. J. Lang, K.-H. Thierauch, C. Müller, G. A. Coles, M. Davies, and J. D. Williams. 1993. Human peritoneal mesothelial cells synthesize interleukin-6: induction by IL-1β and TNFα. Kidney Int. 43:226-233.
37. Saunders, N. A., R. J. Smith, and A. M. Jetten. 1994. Differential responsiveness of human bronchial epithelial cells, lung carcinoma cells, and bronchial fibroblasts to interferon-γ in vitro. Am. J. Respir. Cell Mol. Biol. 11:147-152.